Progreso médico: encefalitis autoinmune contra el receptor de N-metil-D-aspartato asociada a teratomas
Autoimmune encephalitis against the N-methyl-D-aspartate receptor (NMDA-R) is a newly discovered disease that occurs mainly in young women. It is characterized by the presence of autoantibodies against NMDA receptor, specifically against the GluN1 subunit; which generates psychotic symptoms, movemen...
| Autores: | ; ; ; |
|---|---|
| Tipo de documento: | Artículo |
| Estado: | Published version |
| Fecha de publicación: | 2019 |
| País: | Costa Rica |
| Institución: | UCR |
| Repositorio: | Portal de Revistas UCR |
| Lenguaje: | Español |
| OAI Identifier: | oai:portal.ucr.ac.cr:article/37405 |
| Acceso en línea: | https://revistas.ucr.ac.cr/index.php/clinica/article/view/37405 |
| Nivel de acceso: | Acceso abierto |
| Palabra clave: | Anti -NMDA receptor encephalitis; ovarian teratoma; autoimmune encephalitis; paraneoplastic neurological syndromes Encefalitis anti receptor NMDA; teratoma ovárico; encefalitis autoinmune; síndromes neurológicos paraneoplásicos |
| Sumario: | Autoimmune encephalitis against the N-methyl-D-aspartate receptor (NMDA-R) is a newly discovered disease that occurs mainly in young women. It is characterized by the presence of autoantibodies against NMDA receptor, specifically against the GluN1 subunit; which generates psychotic symptoms, movement disorders, autonomic dysfunction and even coma. About 50% of patients present ovarian teratoma when completing the studies. This disease is reversible and treatable, therefore diagnosis and treatment are essential. The first line of treatment includes steroids, intravenous G immunoglobulin or plasmapheresis. The second line consists of rituximab and cyclophosphamide. In addition, in the cases where a tumor is documented, the extirpation of it is considered fundamental. |
|---|